Literature DB >> 21286660

High resolution BrainPET combined with simultaneous MRI.

H Herzog1, K-J Langen, C Weirich, E Rota Kops, J Kaffanke, L Tellmann, J Scheins, I Neuner, G Stoffels, K Fischer, L Caldeira, H H Coenen, N J Shah.   

Abstract

UNLABELLED: After the successful clinical introduction of PET/CT, a novel hybrid imaging technology combining PET with the versatile attributes of MRI is emerging. At the Forschungszentrum Jülich, one of four prototypes available worldwide combining a commercial 3T MRI with a newly developed BrainPET insert has been installed, allowing simultaneous data acquisition with PET and MRI. The BrainPET is equipped with LSO crystals of 2.5 mm width and Avalanche photodiodes (APD) as readout electronics. Here we report on some performance characteristics obtained by phantom studies and also on the initial BrainPET studies on various patients as compared with a conventional HR+ PET-only scanner. MATERIAL,
METHODS: The radiotracers [18F]-fluoro-ethyl-tyrosine (FET), [11C]-flumazenil and [18F]-FP-CIT were applied.
RESULTS: Comparing the PET data obtained with the BrainPET to those of the HR+ scanner demonstrated the high image quality and the superior resolution capability of the BrainPET. Furthermore, it is shown that various MR images of excellent quality could be acquired simultaneously with BrainPET scans without any relevant artefacts. DISCUSSION,
CONCLUSION: Initial experiences with the hybrid MRI/BrainPET indicate a promising basis for further developments of this unique technique allowing simultaneous PET imaging combined with both anatomical and functional MRI.

Entities:  

Mesh:

Year:  2011        PMID: 21286660     DOI: 10.3413/Nukmed-0347-10-09

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  39 in total

Review 1.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

Authors:  Irene Neuner; Joachim B Kaffanke; Karl-Josef Langen; Elena Rota Kops; Lutz Tellmann; Gabriele Stoffels; Christoph Weirich; Christian Filss; Jürgen Scheins; Hans Herzog; N Jon Shah
Journal:  Eur Radiol       Date:  2012-07-11       Impact factor: 5.315

3.  Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.

Authors:  Philipp Lohmann; Hans Herzog; Elena Rota Kops; Gabriele Stoffels; Natalie Judov; Christian Filss; Norbert Galldiks; Lutz Tellmann; Carolin Weiss; Michael Sabel; Heinz Hubert Coenen; Nadim Jon Shah; Karl-Josef Langen
Journal:  Eur Radiol       Date:  2015-03-27       Impact factor: 5.315

4.  Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-L-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake.

Authors:  Carina Stegmayr; Gabriele Stoffels; Elena Rota Kops; Philipp Lohmann; Norbert Galldiks; Nadim J Shah; Bernd Neumaier; Karl-Josef Langen
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

Review 5.  Advances in PET/MR instrumentation and image reconstruction.

Authors:  Jorge Cabello; Sibylle I Ziegler
Journal:  Br J Radiol       Date:  2016-07-22       Impact factor: 3.039

6.  Spatial Relationship of Glioma Volume Derived from 18F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI Study.

Authors:  Jörg Mauler; Andrew A Maudsley; Karl-Josef Langen; Omid Nikoubashman; Gabriele Stoffels; Sulaiman Sheriff; Philipp Lohmann; Christian Filss; Norbert Galldiks; Elena Rota Kops; N Jon Shah
Journal:  J Nucl Med       Date:  2017-08-28       Impact factor: 10.057

7.  Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.

Authors:  Antoine Verger; Christian P Filss; Philipp Lohmann; Gabriele Stoffels; Michael Sabel; Hans J Wittsack; Elena Rota Kops; Norbert Galldiks; Gereon R Fink; Nadim J Shah; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-22       Impact factor: 9.236

Review 8.  Does PET/MR in human brain imaging provide optimal co-registration? A critical reflection.

Authors:  Uwe Pietrzyk; Hans Herzog
Journal:  MAGMA       Date:  2013-01-09       Impact factor: 2.310

9.  Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

Authors:  Norbert Galldiks; Veronika Dunkl; Garry Ceccon; Caroline Tscherpel; Gabriele Stoffels; Ian Law; Otto M Henriksen; Aida Muhic; Hans S Poulsen; Jan Steger; Elena K Bauer; Philipp Lohmann; Matthias Schmidt; Nadim J Shah; Gereon R Fink; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-07       Impact factor: 9.236

Review 10.  PET and MR imaging: the odd couple or a match made in heaven?

Authors:  Ciprian Catana; Alexander R Guimaraes; Bruce R Rosen
Journal:  J Nucl Med       Date:  2013-03-14       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.